Evidence map›Paper›PMID 38855598›Full record

ArticleTranslational andrology and urology2024

Does age impact clinical outcomes of radical nephroureterectomy in the elderly?-results from a multicenter retrospective study.

Mimu Ishikawa, Katsuki Muramoto, Kentaro Yoshihara, Shutaro Yamamoto, Keiichiro Miyajima, Kosuke Iwatani, Yu Imai, Sotaro Kayano, Kagenori Ito, Taro Igarashi and 13 more

Abstract read
In one paragraph

Article in Translational andrology and urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Mimu Ishikawa *Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Katsuki MuramotoDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Kentaro YoshiharaDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Shutaro YamamotoDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Keiichiro MiyajimaDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Kosuke IwataniDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Yu ImaiDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Sotaro KayanoDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Kagenori ItoDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Taro IgarashiDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Keiichiro MoriDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Takafumi YanagisawaDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Shoji KimuraDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Kojiro TashiroDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Shunsuke TsuzukiDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Yuta YamadaDepartment of Urology, University of Tokyo, Tokyo, Japan.
Takaya SasakiDepartment of Nephrology and Hypertension, The Jikei University School of Medicine, Tokyo, Japan.
Shun SatoDepartment of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
Tatsuya ShimomuraDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Akira FurutaDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Jun MikiDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Fumihiko Urabe *Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2599-8183
Takahiro KimuraDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Few studies have addressed the efficacy of nephroureterectomy for managing upper tract urothelial carcinoma (UTUC) in very elderly patients (those aged 85 years and older). We aimed to elucidate the association between age and clinical outcomes in patients with UTUC who underwent radical nephroureterectomy. Methods: We retrospectively analyzed data from 847 patients who underwent nephroureterectomy for UTUC. These patients were classified into four age brackets: young (≤64 years, n=177), intermediate (65-74 years, n=300), elderly (75-84 years, n=312), and very elderly (≥85 years, n=58). We applied logistic regression models to ascertain predictors of postoperative complications. Cox's proportional hazards models were used to evaluate key prognostic factors affecting non-urothelial tract recurrence-free survival (NUTRFS), cancer-specific survival (CSS), and overall survival (OS). Results: In all, 56 patients reported postoperative complications. An Eastern Cooperative Oncology Group performance status ≥2 was identified as a significant predictor for postoperative complications whereas age did not show a noteworthy correlation. Kaplan-Meier survival analyses indicated that very elderly patients had notably poorer OS than younger groups. Nevertheless, the differences in NUTRFS and CSS across the age brackets were not statistically significant. In multivariable analyses, very elderly age was a substantial independent determinant of OS but not NUTRFS or CSS. Conclusions: The therapeutic benefits of surgical procedures are relatively consistent across age groups. This underscores the potential of considering surgical treatment for UTUC in patients aged 85 and above, provided they are deemed fit to withstand the surgical rigors and associated invasiveness.

Indexed as

elderly patientsoncological outcomeUpper tract urothelial carcinoma (UTUC)

Identifiers

PMID38855598
PMCPMC11157401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.